Tolterodine and urinary retention Patient Reports February 11, 2012



Tolterodine Side Effects Report #5187310-8
Tolterodine side effect was reported by a Physician from SPAIN on Dec 05, 2006. Female patient, 61 years of age, was diagnosed with urinary incontinence What is  urinary incontinence and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: anuria, oedema peripheral, urinary retention. Tolterodine dosage: unknown. Patient recovered.

Tolterodine Side Effects Report #4752776-1
Tolterodine side effect was reported by a Health Professional from UNITED KINGDOM on Aug 10, 2005. Male patient, 54 years of age, weighting 165.3 lb, was diagnosed with urinary incontinence What is  urinary incontinence, parkinson's disease What is  parkinson's disease and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: urinary retention. Tolterodine dosage: 4 MG, ORAL. During the same period patient was treated with SINEMET, AMLODIPINE, CITALOPRAM, FOLIC ACID, ACETAMINOPHEN W, VITAMINS. Patient recovered.

Tolterodine Side Effects Report #5049102-X
Tolterodine side effect was reported by a Physician from JAPAN on June 23, 2006. Female patient, 89 years of age, was diagnosed with pollakiuria and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: diabetes mellitus, neurogenic bladder, urinary retention. Tolterodine dosage: 4 MG, ORAL. During the same period patient was treated with FUROSEMIDE. Patient was hospitalized. Patient recovered.

Tolterodine Side Effects Report #5074529-X
Tolterodine side effect was reported by a Physician from JAPAN on July 21, 2006. Male patient, 76 years of age, was diagnosed with pollakiuria and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: prostate cancer What is  prostate cancer, urinary retention. Tolterodine dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with NORVASC, OMEPRAZOLE. Patient was hospitalized. Patient recovered.


Tolterodine Side Effects Report #5085904-1
Tolterodine side effect was reported by a Physician from JAPAN on Aug 04, 2006. Male patient, 76 years of age, was diagnosed with pollakiuria and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: prostatic specific antigen increased, urinary retention. Tolterodine dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with NORVASC, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Tolterodine Side Effects Report #5067460-7
Tolterodine side effect was reported by a Physician from JAPAN on July 14, 2006. Male patient, 81 years of age, weighting 99.21 lb, was diagnosed with nocturia, hypertension and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: urinary retention, vision blurred. Tolterodine dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with NORVASC. Patient recovered.

Tolterodine Side Effects Report #5142900-3
Tolterodine side effect was reported by a Physician from JAPAN on Oct 16, 2006. Female patient, 74 years of age, weighting 121.3 lb, was diagnosed with nocturia, pollakiuria and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: hyperthermia, pyelonephritis, urinary retention. Tolterodine dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with TOLTERODINE TARTRATE, DILTIAZEM HYDROCHLORIDE, LANSOPRAZOLE, MAGNESIUM OXIDE, BROTIZOLAM, MEILAX, DEPAS, SHAKUYAKU. Patient was hospitalized. Patient recovered.

Tolterodine Side Effects Report #5162001-8
Tolterodine side effect was reported by a Physician from JAPAN on Nov 08, 2006. Female patient, 74 years of age, weighting 121.3 lb, was diagnosed with nocturia, pollakiuria and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: cystitis, dysuria, hyperthermia, nocturia, pollakiuria, pyelonephritis, tremor, urinary retention. Tolterodine dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with TOLTERODINE TARTRATE, DILTIAZEM HYDROCHLORIDE, LANSOPRAZOLE, MAGNESIUM OXIDE, BROTIZOLAM, MEILAX, DEPAS, SHAKUYAKU. Patient was hospitalized. Patient recovered.

Tolterodine Side Effects Report #5047040-X
Tolterodine side effect was reported by a Physician from GERMANY on June 23, 2006. Female patient, weighting 202.8 lb, was diagnosed with neurogenic bladder and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: urinary retention, urinary tract infection What is  urinary tract infection. Tolterodine dosage: 4 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with MUSARIL, METFORMIN, BACLOFEN. Patient was hospitalized. Patient recovered.


Tolterodine Side Effects Report #4642986-6
Tolterodine side effect was reported by a Consumer or non-health professional from on Feb 17, 2005. Female patient, 74 years of age, was diagnosed with hypertonic bladder and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: bladder obstruction, urinary retention, uterine prolapse. Tolterodine dosage: unknown. Patient was hospitalized. Patient recovered.

Tolterodine Side Effects Report #5194800-0
Tolterodine side effect was reported by a Physician from MEXICO on Dec 20, 2006. Male patient, weighting 242.5 lb, was diagnosed with hypertonic bladder and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: disease recurrence, refusal of treatment by patient, urinary retention. Tolterodine dosage: unknown. During the same period patient was treated with UROXATRAL. Patient was hospitalized. Patient recovered.

Tolterodine Side Effects Report #5633503-2
Tolterodine side effect was reported by a Consumer or non-health professional from BRAZIL on Feb 11, 2008. Male patient, weighting 123.5 lb, was diagnosed with hypertonic bladder and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: urinary retention. Tolterodine dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, DIAZEPAM, BACLOFEN, SIRDALUD. Patient recovered.

Tolterodine Side Effects Report #6019172-0
Tolterodine side effect was reported by a Physician from JAPAN on Dec 16, 2008. Female patient was diagnosed with hypertonic bladder and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: dizziness What is  dizziness, pollakiuria, sarcoma, urinary retention. Tolterodine dosage: 4 MG, 1X/DAY. During the same period patient was treated with WARFARIN, VALSARTAN, MUCOSOLVAN, DEPAS. Patient was hospitalized. Patient recovered.

Tolterodine Side Effects Report #6058499-3
Tolterodine side effect was reported by a Pharmacist from UNITED STATES on Jan 27, 2009. Male patient, 50 years of age, was treated with Tolterodine. After drug was administered, patient experienced the following side effects: urinary retention. Tolterodine dosage: 4 MG EVERY DAY PO. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Tolterodine